Circulatory syndrome: an evolution of the metabolic syndrome concept!

Ali Reza Khoshdel1, Shane L Carney, Alastair Gillies

  • 1Department of Epidemiology, Faculty of Medicine, AJA University of medical Sciences, Tehran, Iran. alikhoshdel@yahoo.com

Insights

The proposed Circulatory Syndrome refines the metabolic syndrome by adding cardiovascular disease markers like renal impairment and arterial stiffness. This new model aims for a better understanding of cardiovascular risk factors and endothelial damage.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Vascular Biology

Background:

  • Metabolic syndrome is a useful but controversial construct for understanding cardiovascular risk factors.
  • The limitations of metabolic syndrome highlight the critical role of the circulatory system and endothelium in organ function.
  • Emerging cardiovascular disease markers necessitate a refined conceptual framework.

Purpose of the Study:

  • To propose the "Circulatory Syndrome" as an evolution of the metabolic syndrome concept.
  • To integrate recently identified cardiovascular disease markers with established risk factors.
  • To provide a more comprehensive model for understanding cardiovascular disease pathogenesis.

Main Methods:

  • The study conceptually refines the metabolic syndrome by incorporating new markers.
  • It includes factors such as renal impairment, microalbuminuria, arterial stiffness, ventricular dysfunction, and anemia.
  • Classic factors like hypertension, dyslipidemia, and abnormal glucose metabolism are retained.

Main Results:

  • The Circulatory Syndrome integrates traditional metabolic risk factors with newer cardiovascular markers.
  • It acknowledges the interaction of these markers with lifestyle factors (aging, obesity, diet, smoking, inactivity).
  • Common pathways of inflammation, oxidative stress, and hypercoagulability are identified as leading to endothelial damage.

Conclusions:

  • The Circulatory Syndrome offers a refined approach to understanding cardiovascular disease.
  • It builds upon the metabolic syndrome by incorporating a broader range of clinically measurable markers.
  • Further research is needed to fully elucidate the complex interactions within this syndrome and its link to cardiovascular disease.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...